Skip to main content

Table 1 Patient characteristics

From: Randomized phase III trial of radiotherapy or chemoradiotherapy with topotecan and cisplatin in intermediate-risk cervical cancer patients after radical hysterectomy

Clinicopathologic variables

RT

CCRT

CCRT + CT

P value

(N = 13)

(N = 15)

(N = 5)

Age

    

≤50

3

4

1

0.558

>50

10

11

4

 

Cell type

    

Squamous

12

13

5

0.329

Non-squamous

1

2

0

 

Tumor grade

    

I

1

1

0

0.583

II

9

10

3

 

III

3

4

2

 

Stage

    

IB1

1

2

0

0.782

IB2

8

9

3

 

IIA1

2

3

1

 

IIA2

2

1

1

 

Risk factors

    

LTS only

1

2

0

0.489

DSI only

7

7

3

 

LVSI only

0

0

0

 

LTS + DSI

5

5

2

 

LTS + LVSI

0

0

0

 

DSI + LVSI

0

1

0

 

LTS + DSI + LVSI

0

0

0

 
  1. Abbreviations:RT radiotherapy, CCRT chemoradiotherapy, CCRT + CT chemoradiotherapy plus consolidation chemotherapy, LTS large tumor size, DSI deep stromal invasion, LVSI lymphovascular space involvement.
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us